These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616 [TBL] [Abstract][Full Text] [Related]
8. Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder. Monteleone P; Catapano F; Del Buono G; Maj M Acta Psychiatr Scand; 1994 Jun; 89(6):411-5. PubMed ID: 8085472 [TBL] [Abstract][Full Text] [Related]
9. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Pigott TA; Pato MT; Bernstein SE; Grover GN; Hill JL; Tolliver TJ; Murphy DL Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131 [TBL] [Abstract][Full Text] [Related]
14. Fenfluramine stimulation of prolactin in obsessive-compulsive disorder. Hewlett WA; Vinogradov S; Martin K; Berman S; Csernansky JG Psychiatry Res; 1992 Apr; 42(1):81-92. PubMed ID: 1603884 [TBL] [Abstract][Full Text] [Related]
15. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder. Mavissakalian M; Jones B; Olson S; Perel JM Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366 [TBL] [Abstract][Full Text] [Related]
16. Urinary free cortisol levels in obsessive-compulsive disorder. Gehris TL; Kathol RG; Black DW; Noyes R Psychiatry Res; 1990 May; 32(2):151-8. PubMed ID: 2367600 [TBL] [Abstract][Full Text] [Related]
17. Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels. Mavissakalian MR; Jones B; Olson S; Perel JM J Clin Psychopharmacol; 1990 Aug; 10(4):261-8. PubMed ID: 2286699 [TBL] [Abstract][Full Text] [Related]
18. Dexamethasone suppression tests in patients with obsessive-compulsive disorder. Lieberman JA; Kane JM; Sarantakos S; Cole K; Howard A; Borenstein M; Novacenko H; Puig-Antich J Am J Psychiatry; 1985 Jun; 142(6):747-51. PubMed ID: 4003598 [TBL] [Abstract][Full Text] [Related]
19. Seasonal effects in prolactin response to m-chlorophenylpiperazine challenge in obsessive-compulsive disorder. Grossman R; Cohen L; Rosen J; DeCaria C; Hollander E Biol Psychiatry; 1996 Jun; 39(11):982-5. PubMed ID: 9162213 [No Abstract] [Full Text] [Related]
20. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder. Khanna S; John JP; Reddy LP Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]